Literature DB >> 17967475

Recommendations for the reporting of gastric carcinoma.

Marie E Robert1, Laura Lamps, Gregory Y Lauwers.   

Abstract

It has been evident for decades that pathology reports vary between institutions and even within a single institution. Standardization of reporting is the best way to ensure that information necessary for patient management is included in pathology reports. Two societies, the Association of Directors of Anatomic and Surgical Pathology (ADASP) and the College of American Pathologists (CAP) have published guidelines for the reporting of common cancers. Although not identical, the basic content of the ADASP and CAP guidelines are similar. The American College of Surgery Commission on Cancer (COC) accredits cancer centers in the United States. The ADASP has updated all of its protocols to comply with COC requirements in the form of 37 uniform checklists. The checklists utilize criteria sited in the American Joint Committee on Cancer 2002 staging manual and are formatted for ease of use. They may be used as templates for uniform reporting and are designed be compatible with voice-activated transcription.

Entities:  

Mesh:

Year:  2007        PMID: 17967475     DOI: 10.1016/j.humpath.2007.05.024

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.

Authors:  Jesús M Cortés; Giovanni de Petris; José I López
Journal:  Front Med (Lausanne)       Date:  2017-03-06

2.  PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study.

Authors:  Anna Crescenzi; Chiara Taffon; Michele Donati; Michele Pier Luca Guarino; Sergio Valeri; Roberto Coppola
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

3.  Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.

Authors:  Yuezong Bai; Tong Xie; Zhenghang Wang; Shuang Tong; Xiaochen Zhao; Feilong Zhao; Jinping Cai; Xiaofan Wei; Zhi Peng; Lin Shen
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.